These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 21359968)

  • 1. Vascular expression, activity and function of indoleamine 2,3-dioxygenase-1 following cerebral ischaemia-reperfusion in mice.
    Jackman KA; Brait VH; Wang Y; Maghzal GJ; Ball HJ; McKenzie G; De Silva TM; Stocker R; Sobey CG
    Naunyn Schmiedebergs Arch Pharmacol; 2011 May; 383(5):471-81. PubMed ID: 21359968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tryptophan Metabolism in Obesity: The Indoleamine 2,3-Dioxygenase-1 Activity and Therapeutic Options.
    Engin AB; Engin A
    Adv Exp Med Biol; 2024; 1460():629-655. PubMed ID: 39287867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indoleamine 2,3-Dioxygenase Activity During Acute Toxoplasmosis and the Suppressed T Cell Proliferation in Mice.
    Ufermann CM; Domröse A; Babel T; Tersteegen A; Cengiz SC; Eller SK; Spekker-Bosker K; Sorg UR; Förster I; Däubener W
    Front Cell Infect Microbiol; 2019; 9():184. PubMed ID: 31231617
    [No Abstract]   [Full Text] [Related]  

  • 4. L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase.
    Fujigaki S; Saito K; Takemura M; Maekawa N; Yamada Y; Wada H; Seishima M
    Infect Immun; 2002 Feb; 70(2):779-86. PubMed ID: 11796611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice.
    Thaker AI; Rao MS; Bishnupuri KS; Kerr TA; Foster L; Marinshaw JM; Newberry RD; Stenson WF; Ciorba MA
    Gastroenterology; 2013 Aug; 145(2):416-25.e1-4. PubMed ID: 23669411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
    Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
    J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyamidine inhibitors of indoleamine-2,3-dioxygenase potently suppress systemic tryptophan catabolism and the growth of IDO-expressing tumors.
    Koblish HK; Hansbury MJ; Bowman KJ; Yang G; Neilan CL; Haley PJ; Burn TC; Waeltz P; Sparks RB; Yue EW; Combs AP; Scherle PA; Vaddi K; Fridman JS
    Mol Cancer Ther; 2010 Feb; 9(2):489-98. PubMed ID: 20124451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.
    O'Connor JC; Lawson MA; André C; Moreau M; Lestage J; Castanon N; Kelley KW; Dantzer R
    Mol Psychiatry; 2009 May; 14(5):511-22. PubMed ID: 18195714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indoleamine 2,3-Dioxygenase Activity in
    Virok DP; Raffai T; Kókai D; Paróczai D; Bogdanov A; Veres G; Vécsei L; Poliska S; Tiszlavicz L; Somogyvári F; Endrész V; Burián K
    Front Cell Infect Microbiol; 2019; 9():192. PubMed ID: 31249813
    [No Abstract]   [Full Text] [Related]  

  • 10. l-Tryptophan-Induced Vasodilation Is Enhanced in Preeclampsia: Studies on Its Uptake and Metabolism in the Human Placenta.
    Broekhuizen M; Klein T; Hitzerd E; de Rijke YB; Schoenmakers S; Sedlmayr P; Danser AHJ; Merkus D; Reiss IKM
    Hypertension; 2020 Jul; 76(1):184-194. PubMed ID: 32475317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of indoleamine 2,3-dioxygenase by stereoisomers of 1-methyl tryptophan in an experimental graft-versus-tumor model.
    Lim JY; Lee SE; Park G; Choi EY; Min CK
    Exp Hematol; 2014 Oct; 42(10):862-6.e3. PubMed ID: 24971697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IDO Targeting in Sarcoma: Biological and Clinical Implications.
    Nafia I; Toulmonde M; Bortolotto D; Chaibi A; Bodet D; Rey C; Velasco V; Larmonier CB; Cerf L; Adam J; Le Loarer F; Savina A; Bessede A; Italiano A
    Front Immunol; 2020; 11():274. PubMed ID: 32194552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency in indoleamine-2, 3-dioxygenase induces upregulation of guanylate binding protein 1 and inducible nitric oxide synthase expression in the brain during cerebral infection with Toxoplasma gondii in genetically resistant BALB/c mice but not in genetically susceptible C57BL/6 mice.
    Anand N; Lutshumba J; Whitlow M; Abdelaziz MH; Mani R; Suzuki Y
    Microbes Infect; 2022; 24(3):104908. PubMed ID: 34781010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expanding roles of 1-methyl-tryptophan (1-MT): in addition to inhibiting kynurenine production, 1-MT activates the synthesis of melatonin in skin cells.
    Moreno AC; Clara RO; Coimbra JB; Júlio AR; Albuquerque RC; Oliveira EM; Maria-Engler SS; Campa A
    FEBS J; 2013 Oct; 280(19):4782-92. PubMed ID: 23879623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia.
    Saito K; Nowak TS; Markey SP; Heyes MP
    J Neurochem; 1993 Jan; 60(1):180-92. PubMed ID: 8417138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells.
    Opitz CA; Litzenburger UM; Opitz U; Sahm F; Ochs K; Lutz C; Wick W; Platten M
    PLoS One; 2011; 6(5):e19823. PubMed ID: 21625531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain.
    Mazarei G; Budac DP; Lu G; Lee H; Möller T; Leavitt BR
    Exp Neurol; 2013 Nov; 249():144-8. PubMed ID: 23994717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-L-MT, an IDO inhibitor, prevented colitis-associated cancer by inducing CDC20 inhibition-mediated mitotic death of colon cancer cells.
    Liu X; Zhou W; Zhang X; Ding Y; Du Q; Hu R
    Int J Cancer; 2018 Sep; 143(6):1516-1529. PubMed ID: 29607498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indoleamine 2,3-dioxygenase-1, a Novel Therapeutic Target for Post-Vascular Injury Thrombosis in CKD.
    Walker JA; Richards S; Whelan SA; Yoo SB; Russell TL; Arinze N; Lotfollahzadeh S; Napoleon MA; Belghasem M; Lee N; Dember LM; Ravid K; Chitalia VC
    J Am Soc Nephrol; 2021 Nov; 32(11):2834-2850. PubMed ID: 34716244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indolamine 2,3-dioxygenase expression by monocytes and dendritic cell populations in hepatitis C patients.
    Schulz S; Landi A; Garg R; Wilson JA; van Drunen Littel-van den Hurk S
    Clin Exp Immunol; 2015 Jun; 180(3):484-98. PubMed ID: 25605587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.